KPWS
IBB icon

Kestra Private Wealth Services’s iShares Biotechnology ETF IBB Stock Holding History

Kestra Private Wealth Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Buy
7,176
+615
+9% +$105K 0.01% 746
2025
Q4 		$1.11M Buy
6,561
+349
+6% +$56.7K 0.01% 769
2025
Q3 		$897K Sell
6,212
-600
-9% -$81.9K 0.01% 828
2025
Q2 		$862K Buy
6,812
+278
+4% +$34.1K 0.01% 798
2025
Q1 		$836K Buy
6,534
+169
+3% +$22.9K 0.01% 748
2024
Q4 		$842K Buy
6,365
+1,284
+25% +$181K 0.01% 704
2024
Q3 		$740K Buy
5,081
+552
+12% +$79.9K 0.01% 722
2024
Q2 		$622K Sell
4,529
-461
-9% -$61.5K 0.01% 746
2024
Q1 		$685K Sell
4,990
-451
-8% -$61.6K 0.02% 684
2023
Q4 		$739K Sell
5,441
-1,372
-20% -$167K 0.02% 608
2023
Q3 		$833K Sell
6,813
-1,373
-17% -$175K 0.03% 515
2023
Q2 		$1.04M Sell
8,186
-60
-0.7% -$7.79K 0.04% 421
2023
Q1 		$1.07M Buy
8,246
+208
+3% +$27.2K 0.04% 395
2022
Q4 		$1.06M Buy
8,038
+2,166
+37% +$280K 0.05% 360
2022
Q3 		$687K Buy
5,872
+134
+2% +$16.6K 0.04% 413
2022
Q2 		$675K Sell
5,738
-557
-9% -$66.1K 0.04% 419
2022
Q1 		$820K Buy
6,295
+279
+5% +$36.3K 0.04% 427
2021
Q4 		$918K Sell
6,016
-911
-13% -$141K 0.04% 406
2021
Q3 		$1.12M Buy
6,927
+920
+15% +$155K 0.06% 326
2021
Q2 		$983K Buy
6,007
+913
+18% +$141K 0.06% 332
2021
Q1 		$767K Sell
5,094
-770
-13% -$122K 0.05% 356
2020
Q4 		$894K Sell
5,864
-408
-7% -$58.3K 0.07% 299
2020
Q3 		$849K Buy
+6,272
New +$851K 0.07% 269

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kestra Private Wealth Services's IBB Position: Q1 2026 in Review

Kestra Private Wealth Services increased its iShares Biotechnology ETF (IBB) stake by 9.4% in Q1 2026, buying an estimated $105K and bringing the position to 7,176 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #746.

Kestra Private Wealth Services first reported a position in IBB in Q3 2020 and has held it in 23 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Kestra Private Wealth Services held 7,176 shares of iShares Biotechnology ETF worth $1.21M as of Q1 2026.
  • Kestra Private Wealth Services bought 615 iShares Biotechnology ETF shares in Q1 2026, an estimated $105K.
  • iShares Biotechnology ETF made up 0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #746 holding.
  • Kestra Private Wealth Services first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 23 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.